Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

VKTX

Viking Therapeutics (VKTX)

Viking Therapeutics Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:VKTX
DateTimeSourceHeadlineSymbolCompany
04/16/20253:05PMPR Newswire (US)Viking Therapeutics to Report Financial Results for First Quarter 2025 on April 23, 2025NASDAQ:VKTXViking Therapeutics Inc
04/08/20256:05PMEdgar (US Regulatory)Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]NASDAQ:VKTXViking Therapeutics Inc
04/08/20254:25PMEdgar (US Regulatory)Form ARS - Annual Report to Security HoldersNASDAQ:VKTXViking Therapeutics Inc
04/08/20254:23PMEdgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:VKTXViking Therapeutics Inc
04/08/20254:03PMEdgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:VKTXViking Therapeutics Inc
04/02/20255:29PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VKTXViking Therapeutics Inc
03/26/20256:05AMPR Newswire (US)Viking Therapeutics Announces Completion of Enrollment in Phase 2 VENTURE-Oral Dosing Trial of VK2735 Tablet Formulation in Patients with ObesityNASDAQ:VKTXViking Therapeutics Inc
03/11/20256:05AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:VKTXViking Therapeutics Inc
03/11/20256:03AMPR Newswire (US)Viking Therapeutics Signs Broad Manufacturing Agreement With CordenPharma to Support Commercialization of VK2735NASDAQ:VKTXViking Therapeutics Inc
03/04/20253:05PMPR Newswire (US)Viking Therapeutics to Participate at Upcoming Investor ConferencesNASDAQ:VKTXViking Therapeutics Inc
02/26/20253:32PMEdgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:VKTXViking Therapeutics Inc
02/05/20253:07PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:VKTXViking Therapeutics Inc
02/05/20253:05PMPR Newswire (US)Viking Therapeutics Reports Fourth Quarter and Year-End 2024 Financial Results and Provides Corporate UpdateNASDAQ:VKTXViking Therapeutics Inc
01/29/20253:05PMPR Newswire (US)Viking Therapeutics to Report Financial Results for Fourth Quarter and Year-End 2024 on February 5, 2025NASDAQ:VKTXViking Therapeutics Inc
01/08/20256:03AMPR Newswire (US)Viking Therapeutics Announces Initiation of Phase 2 VENTURE-Oral Dosing Trial of VK2735 Tablet Formulation in Patients with ObesityNASDAQ:VKTXViking Therapeutics Inc
01/06/20257:16PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VKTXViking Therapeutics Inc
01/06/20257:15PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VKTXViking Therapeutics Inc
01/06/20257:11PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VKTXViking Therapeutics Inc
01/06/20254:25PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:VKTXViking Therapeutics Inc
01/06/20254:16PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:VKTXViking Therapeutics Inc
01/06/20253:05PMPR Newswire (US)Viking Therapeutics to Present at 43rd Annual J.P. Morgan Healthcare ConferenceNASDAQ:VKTXViking Therapeutics Inc
11/19/20243:03PMPR Newswire (US)Viking Therapeutics Presents Results from Phase 2b VOYAGE Study of VK2809 in Biopsy-Confirmed NASH/MASH at the 75th Liver Meeting® 2024NASDAQ:VKTXViking Therapeutics Inc
11/12/20243:05PMPR Newswire (US)Viking Therapeutics to Present Data from Phase 2b VOYAGE Study of VK2809 in Patients with Biopsy-Confirmed NASH/MASH at the 75th Liver Meeting® 2024NASDAQ:VKTXViking Therapeutics Inc
11/04/20245:31AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:VKTXViking Therapeutics Inc
11/04/20245:30AMPR Newswire (US)Viking Therapeutics Reports New Data from VK2735 Obesity Program at ObesityWeek® 2024NASDAQ:VKTXViking Therapeutics Inc
11/04/20245:20AMIH Market NewsTesla Sales Drop; Intel to Exit Dow Jones After 25 Years; VKTX and ATSG Surge Over 20% Pre-MarketNASDAQ:VKTXViking Therapeutics Inc
10/31/20243:05PMPR Newswire (US)Viking Therapeutics to Participate at Upcoming Investor ConferencesNASDAQ:VKTXViking Therapeutics Inc
10/28/20243:05PMPR Newswire (US)Viking Therapeutics to Highlight Clinical Data from VK2735 Obesity Program in Presentations at ObesityWeek® 2024NASDAQ:VKTXViking Therapeutics Inc
10/25/20246:28PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VKTXViking Therapeutics Inc
10/25/20243:10PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:VKTXViking Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:VKTX